Ozempic, Eating Disorders, and Diabetes: GLP-1 weight loss drugs explained with Dr. Elizabeth Wassenaar

Mental Note

GLP-1 weight loss drugs, such as Ozempic and Wegovy, have exploded in popularity due to their weight-loss potential. But what do they actually do? How do they function? And why are they the subject of so much controversy?

With insight from Dr. Elizabeth Wassenaar, Regional Medical Director for the Eating Recovery Center and Pathlight Mood & Anxiety Center, this episode will empower you to make an educated decision when it comes to your body and these medications.

Crucially, we will also focus on how GLP-1s may affect individuals with eating disorders - even if they are being taken as diabetes medication rather than to lose weight.

If you’d like to learn more about GLp-1s from Dr. Wassenaar — and earn CE credits along the way — join Eating Recovery Center and Pathlight’s virtual annual conference August 21-23 . Dr. Wassenaar will lead a special discussion on GLP-1s and their relationship to Binge Eating Disorder treatment. Sign up here.

Resources:

Mental Note Podcast: www.mentalnotepodcast.com 16th Annual Conference: Register Here Pathlight Mood & Anxiety Center: www.pathlightbh.com Eating Recovery Center: www.eatingrecoverycenter.com Free Group Support: Register Here Free Evaluation with a Trained Therapist: [phone]